IP Verse

Wittkopp competitive analysis

Explore patent oppositions filed by Wittkopp against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 4, 2026

Patent Number	Title	Applicant	Opposition Date
EP4426307	New Oral Pharmaceutical Composition And Dose Regimen For The Therapy Of Progressive Fibrosing Interstitial Lung Diseases	BOEHRINGER INGELHEIM	Apr 2, 2026
EP3449911	Pharmaceutical Formulations	ARRAY BIOPHARMA	Mar 18, 2026
EP3435996	Methods Of Treatment Of Cholestatic Diseases	GENFIT	Jan 29, 2026
EP3592732	Manufacture Of A Crystalline Pharmaceutical Product	ORION	Jan 8, 2026
EP3756650	Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione	AMGEN EUROPE	Dec 19, 2025
EP3798224	Solid State Forms Of Ixazomib Citrate	ASSIA CHEMICAL INDUSTRIES	Dec 19, 2025
EP3490560	Methods Of Treating Prostate Cancer	JANSSEN PHARMACEUTICA	Oct 21, 2025
EP4370116	Methods For Treating Hypertrophic Cardiomyopathy	CYTOKINETICS	Oct 14, 2025
EP3539540	Pharmaceutical Composition, Methods For Treating And Uses Thereof	BOEHRINGER INGELHEIM	Sep 16, 2025
EP3321270	Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-Olate	GILEAD SCIENCES	Sep 2, 2025

Discover the latest PTAB cases involving Wittkopp, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Wittkopp with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 4, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
WITTKOPP	10	-	-	-
ASTRAZENECA	-	28	-	18
BRISTOL MYERS SQUIBB IRELAND	-	43	-	-
BRISTOL MYERS SQUIBB IRELAND UNLIMITED	-	43	-	-